Together world-leading researchers from academia and industry address the urgency of exploring and developing new solutions in the therapeutic space
The COVID-19 pandemic demonstrated mankind’s vulnerability to devastating diseases that threaten not only individuals but also impact the stability of societies and economies around the globe. However, current therapeutics are often insufficient for treatment due to a lack of efficacy and specificity, or are evaded by pathogens due to drug resistance.
It is now clear that there is no ‘one size fits all’ solution, but an urgent need to develop individualized diagnostics and treatments in health systems by turning towards personalized medicine. Hence, it is paramount that academia and industry collaborate in order to continually try to stay ahead of these developments.
With the symposium Life Science Engineering – Expanding the Therapeutic Space DTU Bioengineering will bring together world-leading researchers from academia and industry to address this urgency by exploring new avenues to expand the therapeutic space.
In two main sessions, the symposium explores the latest advancements in antibody technologies and single-cell proteome technologies as two cutting-edge technologies that have the potentials to expand the therapeutic space.